Fluoxetine for childhood anxiety disorders.

Abstract

OBJECTIVE:

The objective of this open study was to determine the efficacy and safety of fluoxetine for the treatment of children and adolescents with anxiety disorders.

METHOD:

Twenty-one patients with overanxious disorders, social phobia, or separation anxiety disorder, who were unresponsive to previous psychopharmacological and psychotherapeutic interventions, were treated openly with fluoxetine for up to 10 months. Patients with lifetime histories of obsessive-compulsive disorder (OCD) or panic disorder, or with current major depression, were excluded. Beneficial and adverse effects of fluoxetine were ascertained using the improvement and severity subscales of the Clinical Global Impression Scale (CGIS) in two ways: (1) independent chart reviews by two child psychiatrists and (2) prospective assessments by the treating nurses and the patients' mothers.

RESULTS:

Eighty-one percent (n = 17) of patients showed moderate to marked improvement in anxiety symptoms. The severity of anxiety as measured by the CGIS was also significantly reduced from marked to mild (effect size: 2.3). There were no significant side effects.

CONCLUSIONS:

These results suggest that fluoxetine may be an effective and safe treatment for nondepressed children and adolescents with anxiety disorders other than OCD and panic disorder. Future investigations using double-blind, placebo-controlled methodologies are warranted.

• Authors: B Birmaher, G S Waterman, N Ryan, M Cully, L Balach, J Ingram, M Brodsky
• Journal: Journal of the American Academy of Child and Adolescent Psychiatry (J Am Acad Child Adolesc Psychiatry) Vol. 33 Issue 7 Pg. 993-9 (Sep 1994) ISSN: 0890-8567 [Print] United States
• PMID: 7961355 (Publication Type: Case Reports, Journal Article)

Chemical References

• Fluoxetine

Topics

• Adolescent
• Anxiety Disorders (drug therapy, psychology)
• Child
• Depressive Disorder (drug therapy, psychology)
• Female
• Fluoxetine (administration & dosage, adverse effects, therapeutic use)
• Humans
• Male
• Psychiatric Status Rating Scales
• Retrospective Studies
• Treatment Outcome